Sensitive, specific and rapid molecular diagnosis of respiratory diseases in animals and humans is critical to facilitate appropriate control measures and treatment. Conventional polymerase chain reaction (PCR)-based molecular diagnostics requires relatively expensive equipment and trained staff, restricting its use to centralized laboratories with significant delays between sample collection and test results. Herein, we report a highly sensitive, rapid, point-of-need, two-stage-molecular test that requires minimal instrumentation and training. Our test, dubbed Penn-RAMP, combines recombinase polymerase amplification (RPA, 38 °C) and loop-mediated isothermal amplification (LAMP, 63 °C) in one tube, enabling nested, two-stage isothermal amplification. We demonstrate Penn-RAMP's efficacy by testing for two common viral respiratory diseases of chickens infectious laryngotracheitis (ILT) and infectious bronchitis (IB) that impose great economic burden worldwide. Test results of clinical samples with our closed-tube Penn-RAMP assays concord with the gold standard quantitative PCR (qPCR) assay; with 10-fold better limit of detection than LAMP and qPCR. Our closed-tube Penn-RAMP assays have the potential to greatly reduce false negatives while requiring minimal instrumentation and training.Four DyIII complexes, [Dy2(NO3)4(L)2(H2O)2]·2MeCN (1), [Dy2(NO3)4(L)2(H2O)2]·2(NO3)·DMBD·2MeOH (2), [Dy2(NO3)4(L)2(TPO)2]·2MeCN (3) and [Dy2(L')6(H2O)2]·4MeCN (4), were elaborately synthesized, structurally characterized and magnetically investigated (HL = 2,6-dimethoxyphenol, HL' = 4-hydroxy-3,5-dimethoxybenzaldehyde, DMBD = 1,1'-dimethyl-[4,4'-bipyridine]-1,1'-diium and TPO = phosphine triphenyl oxide). In 1-3, the nearly planar molecular structures consisting of two DyIII ions and two L ligands are almost perpendicular to four nitrate ligands, which provides an opportunity to introduce auxiliary ligands (H2O or TPO) at the terminal position along the DyDy orientation of [Dy2]. The slightly discrepant coordination environment around the DyIII ion with different terminal ligands plays a key role in tuning the magnetic anisotropy, and further strongly affects the magnetic properties of 1-4. The magnetic studies reveal that they all behave as single-molecule magnets (SMMs) at zero dc field with ferromagnetic dipole-dipole interaction between DyIII ions. The dynamic magnetic investigations give the energy barriers of 107.5 (1), 127.1 (2), 168.7 (3) and 251.9 K (4), respectively. The magnetic axis orientation of the ground state gradually verges on the Dy-Oaux bond from 1 to 4, leading to the stronger uniaxial anisotropy of DyIII ions and better SMM properties of 3 and 4. In addition, complexes 3 and 4 possess higher energy barriers than reported dinuclear DyIII-SMMs also constructed from HL or HL' with β-diketone. It is believed that the ligands coordinating to the DyIII ion at both terminals of the DyDy linkage improve the SMM properties of dinuclear DyIII complexes. This design may provide a new strategy for obtaining dinuclear DyIII-based SMMs.Cataytic bias refers to the propensity of a reaction catalyst to effect a different rate acceleration in one direction versus the other in a chemical reaction under non-equilibrium conditions. In biocatalysis, the inherent bias of an enzyme is often advantagous to augment the innate thermodynamics of a reaction to promote efficiency and fidelity in the coordination of catabolic and anabolic pathways. In industrial chemical catalysis a directional cataltyic bias is a sought after property in facilitating the engineering of systems that couple catalysis with harvest and storage of for example fine chemicals or energy compounds. Interestingly, there is little information about catalytic bias in biocatalysis likely in large part due to difficulties in developing tractible assays sensitive enough to study detailed kinetics. For oxidation-reduction reactions, colorimetric redox indicators exist in a range of reduction potentials to provide a mechanism to study both directions of reactions in a fairly facile manner.  https://www.selleckchem.com/products/pu-h71.html  The current short review attempts to define catalytic bias conceptually and to develop model systems for defining the parameters that control catalytic bias in enzyme catalyzed oxidation-reduction catalysis.Digital homogeneous non-enzymatic immunosorbent assay (digital Ho-Non ELISA) is a new class of digital immunoassay that enables highly sensitive quantification of biomolecules using a simple protocol. In digital Ho-Non ELISA, nanoparticles are tethered onto the surface of femtoliter reactors via captured target molecules. The tethered particles capturing target molecules are identified as those showing a confined Brownian motion with root-mean-square displacement (RMSD) values in a defined range. The present work aims to improve the specificity to discriminate tethered particles via single-target molecules from non-specifically immobilized particles by analyzing two nanoparticle parameters. First, in order to suppress the broadening of RMSD due to the heterogeneity of bead size, we corrected the RMSD with the fluorescence intensity of the beads. Second, focusing on the shape of Brownian motion in the x-y trajectory, we classified motion patterns by aspect ratio of the trajectory. By using multiparameter single-particle motion analysis with corrected RMSD and aspect ratio, a 3.9-fold enhanced sensitivity in PSA assay was achieved compared to the conventional RMSD analysis approach. This new strategy would increase the potential of digital immunoassays.A dual-effective (photothermal and immune) therapy employing gold nanorods (AuNRs) with a drug (two macrophage migration inhibitory factor (MIF) inhibitors) sustained release hydrogel was designed in this paper. The subsequent cellular and animal studies demonstrated that the proposed therapy can not only inhibit the proliferation, migration, and recurrence of cancer cells, but also improve the immune function (increase the infiltration of CD8+ killer T cells in tumors) without the traditional multiple injections of expensive immune drugs.We herein developed a novel tetraarylimidazole-based AIE probe TPIG-NP to selectively image and quantitatively detect glioma. Due to the distinct negatively charged glioma cells, TPIG-NP with an opposite charge could achieve wash-free imaging of glioma cells and 3D multicellular spheroids.